IGFBPs define distinct pro-tumorigenic CAF subtypes in lung cancer tumour-microenvironment
Yengkhom, G. D.; Nandgaonkar, K. K.; Ramanathan, S. K.; Schlegel, J. A.; Dong, M.; Thorat, R.; Kaushal, R. K.; Yadav, S.; Prabhash, K.; Arandkar, S.
Show abstract
Cancer-associated fibroblasts (CAFs) play a significant role in influencing tumour outcomes; however, their heterogeneity and context-sensitive nature present a therapeutically challenging target. Here, we identify a group of Insulin-like growth factor binding proteins (IGFBPs), specifically IGFBP5, 6 and 7, as key regulators of CAF heterogeneity in lung cancer. Notably, these binding proteins are highly expressed in lung CAFs and independently modulate CAF phenotype. We demonstrate that tumour-derived cues, particularly TGF{beta}1 and IL6, affect IGFBP expression in CAFs. Transcriptome studies indicate that selectively knocking down these proteins directs CAFs towards different CAF subtypes. Functionally, CAFs with high levels of IGFBP5, 6, or 7 promote tumour growth in both ex vivo and in vivo settings and, critically, confer cisplatin resistance to tumour cells. Furthermore, the gene signatures associated with these proteins correlate with unfavourable prognosis. In conclusion, our study highlights the phenotypic plasticity of CAFs driven by these three distinct IGFBPs from the same family, consequently influencing the tumour microenvironment landscape.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts 96%
- Loss of EIF4G2 Mediates Aggressiveness in Distinct Human Endometrial Cancer Subpopulations with Poorer Survival Outcome in Patients 96%
- Mast cells interact directly with colorectal cancer cells to promote epithelial-to-mesenchymal transition 95%
Similar papers in this journal
- NAB2-STAT6 drives an EGR1-dependent neuroendocrine program in Solitary Fibrous Tumors 96%
- Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking LAIR-collagen interaction 96%
- Weakly migratory metastatic breast cancer cells activate fibroblasts via microvesicle-Tg2 to facilitate dissemination and metastasis 96%
Similar papers in this journal
- FSTL3 is a biomarker of poor prognosis and is associated with immunotherapy resistance in ovarian cancer. 96%
- Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodeling 95%
- LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.